FIRST SESSION: State of the artChairs: Volker Schuster and Carlo Giaquinto
9:00 Welcome and OpeningMichael Borte, Hans-Iko Huppertz, Volker Schuster
9.10 Rotavirus infection and vaccination: basic facts Hans-Iko Huppertz
9.30 Progress in expansion of rotavirus vaccination in Europe since the 2nd expert meeting in 2011Timo Vesikari
9.50 Update on effectiveness and use of pentavalent rotavirus vaccine, RotaTeqtba
10.10 Update on effectiveness and use of human rotavirus vaccine, Rotarixtba
10.30 Coffee Break
SECOND SESSION: Special TopicsChairs: Michael Borte and Timo Vesikari
11.00 Expansion of rotavirus vaccination in GAVI-eligible countries Duncan Steele
11.20 Porcine circovirus update Federico Martinón-Torres
11.40 Intussusception surveillance in the Americas Manish Patel
12.10 Intussusception reporting in Europe Doris Oberle
12.30 Lunch
THIRD SESSION: Experience with RV universal mass vaccination (UMV)Chairs: Hans-Iko Huppertz and Philippe Lepage
13.30 Unexpected benefits of RV vaccination in the USRoger Glass
FIFTH SESSION: Current Research (1)Chair: Hans-Iko Huppertz
09.00 Molecular epidemiology of rotavirus after UMV in Belgium Jelle Matthijnssens
09.20 RotaTeq double reassortants in vaccine recipients Maria Hemming
09.35 Rotaviruses in Brazil Marco Sáfadi (tbc)
09.50 Resurrection of RotaShield George Armah
10.10 RV in infants with immunodeficiency (including HIV) Carlo Giaquinto
10.30 Coffee Break
SIXTH SESSION: Current Research (2)Chairs: Michael Borte and Pierre van Damme
11.00 RV vaccines in neonates and prematures Pierre van Damme
11.20 Prevention of nosocomial RV infection Patricia Bruijning-Verhagen
11.40 Lactobacillus-mediated protection against rotavirus infectionLennart Hammarström
12.00 Health economics and cost effectiveness tba
12.30 Closing remarks Michael Borte, Hans-Iko Huppertz, Volker Schuster
12.40 Lunch and Departures
13.50 Success of rotavirus UMV in Europe: Austria tbaBelgium Philippe LepageFinland Timo VesikariIsrael Ron Dagan
14.10 Impact of rotavirus vaccination on reducing hospitalizations and deaths from diarrhea in Latin AmericaUmesh Parashar
14.20 Experience of RV vaccination in German Federal States Michael Borte, Volker Schuster, Dietmar Beier, Holm Uhlig, Petra Kaiser
15.30 Coffee Break
FOURTH SESSION: Way forward in EuropeChairs: Volker Schuster
16.00 Status of introduction of RV UMV in Greece Vana Sponlou Latvia Dace ZavadskaNorway Synne Sandbu
16.30 RV Vaccination in Eastern EuropePoland tba Hungary Sophia Meszner Overall picture and comparison in Central and Eastern European countries Roman Prymula Rotavirus Surveillance Network (Georgia, Tajikistan and Ukraine) Duncan Steele
17.15 Panel Discussion: Overcoming hurdles for rotavirus UMV in European countries Carlo Giaquinto (Chair), Adam Finn, Hans-Iko Huppertz, Philippe Lepage
20.00 Social Evening at the Leipzig Zoo
Tuesday, 23 April 2013
Wednesday, 24 April 2013
Local OrganizersProf. Dr. Michael BortePhone: +49-341-9093604E-Mail: Michael.Borte@ sanktgeorg.de Prof. Dr. Hans-Iko HuppertzPhone: +49-421-497-5411 E-Mail: hans-iko.huppertz@ med.uni-goettingen.de
Prof. Dr. Volker Schuster Phone: +49-341-9726844E-Mail: volker.schuster@ medizin.uni-leipzig.de
VenueLeipziger KUBUS
– Das Konferenz- und Bildungszentrum des UFZ Permoserstraße 1504318 Leipzig/Germany
www.rotavirus-leipzig.de
Conference Officeevent lab. GmbHDufourstraße 1504107 Leipzig/GermanyProject Management: Nancy KleinE-Mail: [email protected]: +49-341-240596-60www.eventlab.org
Conference FeesRegular Participants: 80,00 EUR (incl. 19% VAT)
Students: 40,00 EUR (incl. 19% VAT)
!